AstraZeneca hikes guidance as Pfizer date nears
November 06, 2014 at 02:35 AM EST
AstraZeneca, the pharmaceuticals company which this year fended off an approach from Pfizer, has raised its sales forecasts again.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.